Weight-loss drugs like Ozempic and Wegovy are continuing to spook financial advisers when it comes to companies. Some experts predict these companies - already battling a rise in health conscious customers - could face a tobacco-like demise due to the increasingly popular drugs, which reduce cravings and make people feel full longer. The doughnut company Krispy Kreme is the latest to feel the effects of the weight-loss movement and saw its share price drop Monday.
Load More
Load More